Heron Therapeutics (AXD2) Q4 2022 Earnings Report

4 Followers

DE:AXD2 Q4 2022 EPS Results

Actual EPS: -EUR 0.15
Consensus EPS: -EUR 0.28
Beat/Miss: Beat by +EUR 0.13
One Year Ago EPS: -EUR 0.48

DE:AXD2 Q4 2022 Revenue Results

Actual Revenue: EUR 26.89M
Expected Revenue: EUR 24.39M
Beat/Miss: Beat by +EUR 2.50M
YoY Revenue Growth: +45.38%

Earnings Announcement Details

Quarter: Q4 2022
Date: 03/23/2023
Time: After Close
Conference Call: Thursday, March 23, 2023

DE:AXD2 Upcoming Earnings

Heron Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

DE:AXD2 Q4 2022 Earnings Call

0:00 / 0:00

Q4 2022 Earnings Slide Deck

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:AXD2 Earnings History

DE:AXD2 earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 04, 2027	2026 (Q4)	-0.03-	-0.02	―	―
Nov 09, 2026	2026 (Q3)	-0.02-0.03	-0.09	70.00% (+0.06)
Aug 10, 2026	2026 (Q2)	-0.00-0.03	-0.02	-50.00% (-0.01)
May 11, 2026	2026 (Q1)	-0.02-0.04	0.01	-500.00% (-0.04)
Feb 26, 2026	2025 (Q4)	-0.02-0.02	0.02	-200.00% (-0.04)
Nov 04, 2025	2025 (Q3)	-0.01-0.09	-0.03	-233.33% (-0.06)
Aug 08, 2025	2025 (Q2)	-0.01-0.02	-0.05	66.67% (+0.04)
May 06, 2025	2025 (Q1)	-0.010.01	-0.02	150.00% (+0.03)
Feb 27, 2025	2024 (Q4)	-0.030.02	-0.06	128.57% (+0.08)
Nov 12, 2024	2024 (Q3)	-0.03-0.03	-0.15	82.35% (+0.13)
Aug 06, 2024	2024 (Q2)	-0.03-0.05	-0.31	82.86% (+0.26)
May 07, 2024	2024 (Q1)	-0.07-0.02	-0.24	92.59% (+0.22)
Mar 12, 2024	2023 (Q4)	-0.14-0.06	-0.15	58.82% (+0.09)
Nov 14, 2023	2023 (Q3)	-0.26-0.15	-0.34	55.26% (+0.19)
Aug 14, 2023	2023 (Q2)	-0.20-0.31	-0.49	36.36% (+0.18)
May 11, 2023	2023 (Q1)	-0.19-0.24	-0.56	57.14% (+0.32)
Mar 23, 2023	2022 (Q4)	-0.28-0.15	-0.48	68.52% (+0.33)
Nov 08, 2022	2022 (Q3)	-0.34-0.34	-0.46	25.49% (+0.12)
Aug 09, 2022	2022 (Q2)	-0.48-0.49	-0.56	11.29% (+0.06)
May 09, 2022	2022 (Q1)	-0.43-0.56	-0.52	-8.62% (-0.04)
Feb 28, 2022	2021 (Q4)	-0.52-0.48	-0.61	20.59% (+0.13)
Nov 03, 2021	2021 (Q3)	-0.54-0.46	-0.57	20.31% (+0.12)
Aug 09, 2021	2021 (Q2)	-0.50-0.56	-0.55	-1.64% (-0.01)
May 10, 2021	2021 (Q1)	―-0.52	-0.51	-1.75% (-0.01)
Feb 24, 2021	2020 (Q4)	―-0.61	-0.58	-4.62% (-0.03)
Nov 05, 2020	2020 (Q3)	―-0.57	-0.38	-52.38% (-0.20)
Aug 05, 2020	2020 (Q2)	―-0.55	-0.56	3.17% (+0.02)
May 06, 2020	2020 (Q1)	―-0.51	-0.72	28.75% (+0.21)
Mar 02, 2020	2019 (Q4)	―-0.58	-0.56	-3.17% (-0.02)
Nov 12, 2019	2019 (Q3)	―-0.38	-0.44	14.29% (+0.06)
Aug 05, 2019	2019 (Q2)	―-0.56	-0.48	-16.67% (-0.08)
May 09, 2019	2019 (Q1)	―-0.72	-0.73	1.23% (+0.01)
Feb 22, 2019	2018 (Q4)	―-0.56	-0.98	42.20% (+0.41)
Nov 07, 2018	2018 (Q3)	―-0.44	-0.69	36.36% (+0.25)
Aug 08, 2018	2018 (Q2)	―-0.48	-0.72	32.50% (+0.23)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Heron Therapeutics earnings date